Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 54.270 | 54.270 | 0.000 |
Shares | 45.730 | 45.730 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.000 | 21.770 |
Price to Book | 3.534 | 3.989 |
Price to Sales | 1.736 | 2.260 |
Price to Cash Flow | 10.512 | 16.880 |
Dividend Yield | 0.950 | 1.345 |
5 Years Earnings Growth | 13.942 | 11.341 |
Number of long holdings: 19
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Horizon Therapeutics PLC | IE00BQPVQZ61 | 4.80 | - | - | |
Halozyme | US40637H1095 | 4.01 | 44.29 | +2.17% | |
IQVIA Holdings | US46266C1053 | 3.76 | 219.10 | -1.51% | |
Harmony Bio | US4131971040 | 3.72 | 29.40 | +1.84% | |
Jazz Pharma | IE00B4Q5ZN47 | 3.64 | 105.25 | -0.20% | |
Pfizer | US7170811035 | 3.58 | 28.66 | +1.63% | |
HCA | US40412C1018 | 3.58 | 339.61 | +1.35% | |
Centene | US15135B1017 | 3.55 | 71.59 | +3.81% | |
Danaher | US2358511028 | 3.23 | 256.80 | +1.61% | |
BioNTech | US09075V1026 | 2.96 | 100.60 | +1.87% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto CH IPF I Index Equity Fu | 6.6B | 10.60 | 8.37 | 9.76 | ||
Swisscanto CH IPF III Index EquAST | 3.81B | 10.63 | 7.97 | 9.33 | ||
Swisscanto CH IPF I Index Equity CH | 2.32B | 14.70 | 6.38 | 9.88 | ||
CH0315621927 | 1.86B | 9.13 | -6.73 | - | ||
CH0011792451 | 859.29M | -19.58 | 1.16 | 7.27 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review